알리코제약

Business Overview

Alico Pharmaceutical, established in 1992, operates in pharmaceutical manufacturing and sales, CMO, overseas exports, medical device production, and the development and sale of health functional foods and cosmetics. The company expanded its central research institute in 2020 to enhance new growth initiatives. It has maintained profitability, achieving a 13.69% CAGR in revenue from 2012 to 2025. Alico aims to capitalize on increasing pharmaceutical demand driven by an aging population and is expanding into medical devices, cosmetics, and other sectors to strengthen revenue and growth.